Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
- Bushra Naheed,
- Jan Herman Kuiper,
- Olalekan A Uthman,
- Fidelma O'Mahony,
- Patrick Michael Shaughn O'Brien
Cochrane Database Syst Rev 2017 Mar 3;3:CD010503. Epub 2017 Mar 3.
Academic Department of Obstetrics and Gynaecology, Keele University Medical School, North Staffordshire Hospital, City General Hospital, Newcastle Road, Stoke-on-Trent, Staffordshire, UK, ST4 6QG.
Background: Premenstrual syndrome (PMS) is a psychological and somatic disorder of unknown aetiology, with symptoms typically including irritability, depression, mood swings, bloating, breast tenderness and sleep disturbances. About 3% to 10% of women who experience these symptoms may also meet criteria for premenstrual dysphoric disorder (PMDD). PMS symptoms recur during the luteal phase of the menstrual cycle and reduce by the end of menstruation. Read More